PuSH - Publikationsserver des Helmholtz Zentrums München

18 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Bissinger, R.* et al.: Proteinuric chronic kidney disease is associated with altered red blood cell lifespan, deformability and metabolism. Kidney Int., DOI: 10.1016/j.kint.2021.08.024 (2021)
2.
Bohnert, B.N. et al.: The Case | A 74-year-old liver transplant recipient with nephrotic-range proteinuria. Kidney Int. 99, 1031-1032 (2021)
3.
Gorski, M.* et al.: Meta-analysis uncovers genome-wide significant variants for rapid kidney function decline. Kidney Int. 99, 926-939 (2021)
4.
Artunc, F.: Kidney-derived PCSK9-a new driver of hyperlipidemia in nephrotic syndrome? Kidney Int. 98, 1393-1395 (2020)
5.
Pastor-Arroyo, E.M.* et al.: The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk. Kidney Int. 94, 49-59 (2018)
6.
Bohnert, B.N. et al.: Aprotinin prevents proteolytic epithelial sodium channel (ENaC) activation and volume retention in nephrotic syndrome. Kidney Int. 93, 159-172 (2017)
7.
Gorski, M.* et al.: Genome-wide association study of kidney function decline in individuals of European descent. Kidney Int. 87, 1017–1029 (2015)
8.
Seleznik, G.M.* et al.: The lymphotoxin β receptor is a potential therapeutic target in renal inflammation. Kidney Int. 89, 113–126 (2015)
9.
Pattaro, C.* et al.: Genome-wide linkage analysis of serum creatinine in three isolated European populations. Kidney Int. 76, 297-306 (2009)
10.
Segerer, S.* et al.: Compartment specific expression of dendritic cell markers in human glomerulonephritis. Kidney Int. 74, 37-46 (2008)
11.
Frischmann, M.E.* et al.: In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients. Kidney Int. 71, 1036-1043 (2007)
12.
Kollerits, B.* ; Fliser, D.* ; Heid, I.M. ; Ritz, E.* & Kronenberg, F.*: Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: The Mild to Moderate Kidney Disease Study. Kidney Int. 71, 1279-1286 (2007)
13.
Segerer, S.* et al.: Expression of the chemokine receptor CXCR1 in human glomerular disease. Kidney Int. 69, 1765-1773 (2006)
14.
Haiman, M.* et al.: Immunohistochemical localization of apolipoprotein A-IV in human kidney tissue. Kidney Int. 68, 1130-1136 (2005)
15.
Kronenberg, F. et al.: Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome: Impact on lipid-lowering therapy? Kidney Int. 66, 348-354 (2004)
16.
Kronenberg, F. et al.: The apolipoprotein(a) size polymorphism is associated with nephrotic syndrome. Kidney Int. 65, 606-612 (2004)
17.
Kronenberg, F. et al.: Prevalence of dyslipidemic risk factors in hemodialysis and CAPD patients. Kidney Int. 63, Suppl.84, 113-116 (2003)
18.
White, K.E.* et al.: Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int. 60, 2079-2086 (2001)